Xiaomu Wei

Cornell University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index7.7kcitations64works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Histone Deacetylase Inhibitors Research(17), Multiple Myeloma Research and Treatments(15), Bioinformatics and Genomic Networks(12), Epigenetics and DNA Methylation(8), Melanoma and MAPK Pathways(8)

Publications64 total

Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees
Cancers·2025Open Access
Data from Mutational and Functional Analysis Reveals <i>ADAMTS18</i> Metalloproteinase as a Novel Driver in Melanoma
2023Open Access
Supplementary Figures 1-4, Tables 1-6 from Mutational and Functional Analysis Reveals <i>ADAMTS18</i> Metalloproteinase as a Novel Driver in Melanoma
2023Open Access
Data from Mutational and Functional Analysis Reveals <i>ADAMTS18</i> Metalloproteinase as a Novel Driver in Melanoma
2023Open Access
Supplementary Figures 1-4, Tables 1-6 from Mutational and Functional Analysis Reveals <i>ADAMTS18</i> Metalloproteinase as a Novel Driver in Melanoma
2023Open Access
Supplementary Figure S1 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Figure S2 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Table S3 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Table S2 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Data from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Figure S2 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Table S2 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Table S1 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Data from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Table S1 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Table S3 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Figure S1 from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Data from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
Supplementary Data from Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma
2023Open Access
A full-proteome, interaction-specific characterization of mutational hotspots across human cancers
Genome Research·2021· 6 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Haiyuan Yu(24), Steven M. Lipkin(23), Steven A. Rosenberg(15), Yardena Samuels(15), James McKay(14), Charles Dumontet(14), Celine M. Vachon(13), Nicola J. Camp(13), Robert J. Klein(13), Joseph Vijai(12), Karen Curtin(12), Susan L. Slager(12), Kenneth Offit(12), Todd D. Prickett(11), Siwei Chen(11), David Jayabalan(11), Djordje Atanackovic(11), Rosalie Waller(11), María V. Revuelta(10), Jared J. Gartner(9)